GSK plc (BVMF:G1SK34)

GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of BRL 509.48 billion. The enterprise value is 607.16 billion.

Market Cap	509.48B
Enterprise Value	607.16B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	85.43%
Float	3.88B

Valuation Ratios

The trailing PE ratio is 12.94 and the forward PE ratio is 10.11.

PE Ratio	12.94
Forward PE	10.11
PS Ratio	2.21
PB Ratio	4.51
P/TBV Ratio	n/a
P/FCF Ratio	10.99
P/OCF Ratio	9.13
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.97, with an EV/FCF ratio of 13.09.

EV / Earnings	15.43
EV / Sales	2.71
EV / EBITDA	8.97
EV / EBIT	12.82
EV / FCF	13.09

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.13.

Current Ratio	0.84
Quick Ratio	0.54
Debt / Equity	1.13
Debt / EBITDA	1.82
Debt / FCF	2.74
Interest Coverage	10.96

Financial Efficiency

Return on equity (ROE) is 41.52% and return on invested capital (ROIC) is 13.51%.

Return on Equity (ROE)	41.52%
Return on Assets (ROA)	7.13%
Return on Invested Capital (ROIC)	13.51%
Return on Capital Employed (ROCE)	17.02%
Revenue Per Employee	3.36M
Profits Per Employee	573,484
Employee Count	68,629
Asset Turnover	0.54
Inventory Turnover	1.47

Taxes

In the past 12 months, GSK plc has paid 6.81 billion in taxes.

Income Tax	6.81B
Effective Tax Rate	13.56%

Stock Price Statistics

The stock price has increased by +20.58% in the last 52 weeks. The beta is 0.23, so GSK plc's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	+20.58%
50-Day Moving Average	44.81
200-Day Moving Average	43.02
Relative Strength Index (RSI)	67.55
Average Volume (20 Days)	61

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of BRL 230.43 billion and earned 39.36 billion in profits. Earnings per share was 9.52.

Revenue	230.43B
Gross Profit	166.91B
Operating Income	48.78B
Pretax Income	50.25B
Net Income	39.36B
EBITDA	68.19B
EBIT	48.78B
Earnings Per Share (EPS)	9.52

Balance Sheet

The company has 23.68 billion in cash and 127.16 billion in debt, giving a net cash position of -103.47 billion.

Cash & Cash Equivalents	23.68B
Total Debt	127.16B
Net Cash	-103.47B
Net Cash Per Share	n/a
Equity (Book Value)	112.84B
Book Value Per Share	28.73
Working Capital	-25.02B

Cash Flow

In the last 12 months, operating cash flow was 55.82 billion and capital expenditures -9.45 billion, giving a free cash flow of 46.37 billion.

Operating Cash Flow	55.82B
Capital Expenditures	-9.45B
Free Cash Flow	46.37B
FCF Per Share	n/a

Margins

Gross margin is 72.43%, with operating and profit margins of 21.17% and 17.08%.

Gross Margin	72.43%
Operating Margin	21.17%
Pretax Margin	21.81%
Profit Margin	17.08%
EBITDA Margin	29.59%
EBIT Margin	21.17%
FCF Margin	20.12%

Dividends & Yields

This stock pays an annual dividend of 1.79, which amounts to a dividend yield of 3.54%.

Dividend Per Share	1.79
Dividend Yield	3.54%
Dividend Growth (YoY)	16.66%
Years of Dividend Growth	1
Payout Ratio	46.05%
Buyback Yield	-0.08%
Shareholder Yield	3.46%
Earnings Yield	7.73%
FCF Yield	9.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GSK plc has an Altman Z-Score of 1.81 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.81
Piotroski F-Score	7